1. Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada
Despite decades of major advances in the treatment of patients with heart failure (HF), morbidity and mortality remain high regardless of aetiology. Increased left atrial pressure (LAP) leading to pulmonary congestion is the main mechanism precipitating acute decompensation and the worsening of symptoms. Implantable haemodynamic pressure monitoring has been shown to decrease HF hospitalisation and improve outcomes by guiding dose titration of drugs impacting on LAP1. Despite the benefits of device-guided therapy, it should be noted that most HF patients are elderly and exhibit multiple comorbidities which may represent a challenge for both medication self-titration and close follow-up. The ...
Sign in to read and download the full articleForgot your password?
No account yet? Sign up for free!Create my pcr account
Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com
Read next articleWorking across borders: EAPCI and the National Societies